FY2024 audited accounts confirm preliminary numbers in line with guidance
Q1/2025 sales up +13%, adj. EBITDA surges +28%, margin reaches Vision 2025 target
Sales grow +15% to € 2.3 billion, profitability jumps +23%
FY2024 preliminary numbers in line with capital market guidance published in July 2024
Group adj. EBITDA grows by 23%, in Europe the margin is up +2.1 %pt. (to 22.8%)
Lothes is the first American on Fielmann Group’s Management Board; Demonstrates Company’s Commitment to Empower US Eyewear Customers
Fielmann Group’s price leadership as well as its international expansion lead to +13% growth in the first nine months (organic growth +5%, US acquisitions +8%)
ISS ESG, one of the most renowned rating companies for sustainable and responsible investments, has awarded the Fielmann Group a Prime Status ESG rating in the Healthcare category.
Strong sales growth across all major markets despite weak consumer sentiment in Europe
Customer loyalty, sell-out structure and Cost Leadership Program drive HY1/2024 EBITDA margin in European markets up by 2 percentage points to about 23%
